[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:rhabdomyosarcoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":285,"states":294},"Rhabdomyosarcoma",46,42,[8,16,23,30,36,42,48,54,60,66,72,78,84,90,96,102,108,114,120,126,132,138,144,149,155,161,167,173,179,185,191,197,202,208,214,220,225,231,237,243,248,253,259,266,272,278],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06865664","FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma",[12],"Phase 1","RECRUITING","2026-08-26T02:16:09.452956Z","2026-05-05T02:43:29.335285Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT04796012","VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed\u002FRefractory Solid Tumors",[20],"Phase 1\u002FPhase 2","2026-08-26T02:16:51.982021Z","2026-05-05T02:43:28.853446Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT06023641","Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease",[27],"Phase 2","2026-08-26T02:16:12.203827Z","2026-05-05T02:43:27.732447Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT06941272","A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C\u002FLIGHTBEAM-U01)",[20],"2026-08-26T02:16:28.221034Z","2026-07-19T19:36:05.059044Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT07172958","Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed\u002FRefractory Embryonal Tumors (SABRE)",[12],"2026-08-26T02:15:26.669629Z","2026-05-05T02:43:29.230684Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06721689","PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors",[20],"2026-08-26T02:19:14.560989Z","2026-05-05T02:43:28.347885Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT05210374","Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas",[12],"2026-08-26T02:15:20.225313Z","2026-05-05T02:43:27.805890Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT05634369","A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue",[20],"2026-08-26T02:17:41.695983Z","2026-05-05T02:35:31.762190Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT06625190","Alpha\u002FBeta T and B Cell Depletion With Zoledronic Acid for Solid Tumors",[20],"2026-08-26T02:19:04.543908Z","2026-07-05T03:45:20.453806Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT06541262","Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors",[20],"2026-08-26T02:16:21.385056Z","2026-07-05T03:45:20.453347Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT06198296","Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells",[12],"2026-08-26T02:16:39.977107Z","2026-05-05T02:43:29.711287Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT07148050","Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells",[12],"2026-08-26T02:17:16.126291Z","2026-05-05T02:43:29.698343Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT02508038","Alpha\u002FBeta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors",[12],"2026-08-26T02:17:26.640202Z","2026-05-05T02:43:29.192915Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT05135975","A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors",[27],"2026-08-26T02:16:46.147215Z","2026-05-05T02:43:28.530799Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT04308330","Vorinostat in Combination With Chemotherapy in Relapsed\u002FRefractory Solid Tumors and CNS Malignancies",[12],"2026-08-26T02:19:10.436356Z","2026-05-05T02:43:28.511395Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT04897321","B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)",[12],"2026-08-26T02:16:45.157238Z","2026-05-05T02:43:28.511090Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":112,"content_modified":113},"NCT05857969","Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling",[12],"2026-08-26T02:18:00.873391Z","2026-05-05T02:43:28.220097Z",{"nct_id":115,"title":116,"phases":117,"status":13,"updated_at":118,"content_modified":119},"NCT04995003","HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma",[12],"2026-08-26T02:16:31.714843Z","2026-05-05T02:43:27.987147Z",{"nct_id":121,"title":122,"phases":123,"status":13,"updated_at":124,"content_modified":125},"NCT05238792","Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors",[12],"2026-08-26T02:19:28.327680Z","2026-05-05T02:43:27.959678Z",{"nct_id":127,"title":128,"phases":129,"status":13,"updated_at":130,"content_modified":131},"NCT02390752","Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...",[12],"2026-08-26T02:17:48.768272Z","2026-05-05T02:43:27.488578Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":136,"content_modified":137},"NCT01804634","Reduced Intensity Haploidentical BMT for High Risk Solid Tumors",[27],"2026-08-26T02:15:50.539717Z","2026-05-05T02:43:27.448232Z",{"nct_id":139,"title":140,"phases":141,"status":13,"updated_at":142,"content_modified":143},"NCT04715191","Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors",[12],"2026-08-26T02:16:35.654046Z","2026-05-05T02:43:27.425045Z",{"nct_id":145,"title":146,"phases":147,"status":13,"updated_at":130,"content_modified":148},"NCT07222735","Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed\u002FRefractory Sarcomas",[12],"2026-05-05T02:43:27.273704Z",{"nct_id":150,"title":151,"phases":152,"status":13,"updated_at":153,"content_modified":154},"NCT05253131","Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas",[27],"2026-08-26T02:15:37.042762Z","2026-05-05T02:43:27.251035Z",{"nct_id":156,"title":157,"phases":158,"status":13,"updated_at":159,"content_modified":160},"NCT06709495","Phase 1\u002F2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas",[20],"2026-08-26T02:16:24.135291Z","2026-05-05T02:43:27.245630Z",{"nct_id":162,"title":163,"phases":164,"status":13,"updated_at":165,"content_modified":166},"NCT04469530","Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors",[27],"2026-08-26T02:18:49.989941Z","2026-05-05T02:43:27.107017Z",{"nct_id":168,"title":169,"phases":170,"status":13,"updated_at":171,"content_modified":172},"NCT06441331","Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors",[12],"2026-08-26T02:18:55.570428Z","2026-05-05T02:43:26.707134Z",{"nct_id":174,"title":175,"phases":176,"status":13,"updated_at":177,"content_modified":178},"NCT04901702","Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma",[20],"2026-08-26T02:18:32.765187Z","2026-05-05T02:35:31.688370Z",{"nct_id":180,"title":181,"phases":182,"status":13,"updated_at":28,"content_modified":184},"NCT02446431","Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence",[183],"Early Phase 1","2026-05-05T02:43:28.295351Z",{"nct_id":186,"title":187,"phases":188,"status":13,"updated_at":189,"content_modified":190},"NCT05645523","Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors",[183],"2026-08-26T02:17:52.450442Z","2026-05-05T02:43:29.709442Z",{"nct_id":192,"title":193,"phases":194,"status":13,"updated_at":195,"content_modified":196},"NCT04199741","PET\u002FCT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56",[20],"2026-08-26T02:18:04.640417Z","2026-07-05T05:32:16.773657Z",{"nct_id":198,"title":199,"phases":200,"status":13,"updated_at":100,"content_modified":201},"NCT04084067","Indocyanine Green (ICG) Guided Tumor Resection",[12],"2026-05-05T02:43:28.715739Z",{"nct_id":203,"title":204,"phases":205,"status":13,"updated_at":206,"content_modified":207},"NCT06235125","Safety and Feasibility of Intraoperative Visualization With Cytalux in Children",[12],"2026-08-26T02:16:02.918558Z","2026-05-05T02:43:27.069602Z",{"nct_id":209,"title":210,"phases":211,"status":13,"updated_at":212,"content_modified":213},"NCT07054944","Tumor-Lymph Node Mapping",[],"2026-08-26T02:18:48.678868Z","2026-05-13T02:55:06.609189Z",{"nct_id":215,"title":216,"phases":217,"status":13,"updated_at":218,"content_modified":219},"NCT07630974","A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D\u002FLIGHTBEAM-U01)",[20],"2026-08-26T02:18:46.137046Z","2026-07-19T19:36:05.145854Z",{"nct_id":221,"title":222,"phases":223,"status":13,"updated_at":165,"content_modified":224},"NCT07698899","A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)",[12],"2026-07-19T19:36:05.081790Z",{"nct_id":226,"title":227,"phases":228,"status":13,"updated_at":229,"content_modified":230},"NCT05033288","Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone",[],"2026-08-26T02:17:15.156099Z","2026-05-13T02:55:06.280317Z",{"nct_id":232,"title":233,"phases":234,"status":13,"updated_at":235,"content_modified":236},"NCT03050268","Familial Investigations of Childhood Cancer Predisposition",[],"2026-08-26T02:17:18.747857Z","2026-05-13T02:55:06.107926Z",{"nct_id":238,"title":239,"phases":240,"status":13,"updated_at":241,"content_modified":242},"NCT01120353","Childhood Cancer Survivor Study",[],"2026-08-26T02:18:27.904411Z","2026-05-13T02:55:06.067987Z",{"nct_id":244,"title":245,"phases":246,"status":13,"updated_at":46,"content_modified":247},"NCT06796543","Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma",[],"2026-04-29T02:57:57.116969Z",{"nct_id":249,"title":250,"phases":251,"status":13,"updated_at":112,"content_modified":252},"NCT07628634","Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w\u002F Solid Tumors",[183],"2026-06-06T00:48:49.527814Z",{"nct_id":254,"title":255,"phases":256,"status":13,"updated_at":257,"content_modified":258},"NCT07514819","Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma",[],"2026-08-26T02:19:08.862440Z","2026-05-05T02:43:26.679931Z",{"nct_id":260,"title":261,"phases":262,"status":263,"updated_at":264,"content_modified":265},"NCT07224568","Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors",[12],"NOT_YET_RECRUITING","2026-08-26T02:15:28.524219Z","2026-05-05T02:43:26.899812Z",{"nct_id":267,"title":268,"phases":269,"status":263,"updated_at":270,"content_modified":271},"NCT06029465","Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials",[],"2026-08-26T02:16:47.762107Z","2026-05-13T02:55:06.401894Z",{"nct_id":273,"title":274,"phases":275,"status":263,"updated_at":276,"content_modified":277},"NCT07516353","my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults",[],"2026-08-26T02:16:01.079019Z","2026-05-05T02:43:29.524607Z",{"nct_id":279,"title":280,"phases":281,"status":282,"updated_at":283,"content_modified":284},"NCT04337177","Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T03:02:58.488119Z","2026-05-05T02:43:28.743177Z",[286,290],{"biomarker":287,"count":288,"slug":289},"Glypican-3",4,"glypican-3",{"biomarker":291,"count":292,"slug":293},"CD276 wt Allele",3,"cd276-wt-allele",[295,299,303,306,310,313,317,320,324,327,330,333,337,340,343,346,349,352,355,358],{"state":296,"count":297,"slug":298},"Texas",14,"texas",{"state":300,"count":301,"slug":302},"California",12,"california",{"state":304,"count":301,"slug":305},"Tennessee","tennessee",{"state":307,"count":308,"slug":309},"New York",10,"new-york",{"state":311,"count":308,"slug":312},"Pennsylvania","pennsylvania",{"state":314,"count":315,"slug":316},"District of Columbia",7,"district-of-columbia",{"state":318,"count":315,"slug":319},"Massachusetts","massachusetts",{"state":321,"count":322,"slug":323},"Florida",6,"florida",{"state":325,"count":322,"slug":326},"Missouri","missouri",{"state":328,"count":322,"slug":329},"Ohio","ohio",{"state":331,"count":322,"slug":332},"Utah","utah",{"state":334,"count":335,"slug":336},"Alabama",5,"alabama",{"state":338,"count":288,"slug":339},"Arizona","arizona",{"state":341,"count":288,"slug":342},"Colorado","colorado",{"state":344,"count":288,"slug":345},"Georgia","georgia",{"state":347,"count":288,"slug":348},"Illinois","illinois",{"state":350,"count":288,"slug":351},"Maryland","maryland",{"state":353,"count":288,"slug":354},"Minnesota","minnesota",{"state":356,"count":288,"slug":357},"New Jersey","new-jersey",{"state":359,"count":288,"slug":360},"Washington","washington"]